BDRX Stock Summary and Trading Ideas (Biodexa Pharmaceuticals PLC - American Depositary Shares | NASDAQ:BDRX)

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

Biodexa Pharmaceuticals PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol BDRX.

As of September 17, 2026, BDRX stock price declined to $0.80 with 1,293,727 million shares trading.

BDRX has a beta of 1.98, meaning it tends to be more sensitive to market movements. BDRX has a correlation of 0.04 to the broad based SPY ETF.

BDRX has a market cap of $823,150.00. This is considered a Sub-Micro Cap stock.

In the last 3 years, BDRX traded as high as $11,012.50 and as low as $.61.

BDRX has underperformed the market in the last year with a return of -97.4%, while the SPY ETF gained +16.7%. In the last 3 month period, BDRX fell short of the market, returning -73.2%, while SPY returned +1.9%. However, in the most recent 2 weeks BDRX has outperformed the stock market by returning +1.9%, while SPY returned -0.3%.

BDRX support price is $.86 and resistance is $1.06 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BDRX shares will trade within this expected range on the day.